Determination of Glycemic Response after Ingestion of Industrialized Enteral Diets Usually Used in Clinical Practice

Glycemic Index of Enteral Formulas and Effect on Glycemic Control of Hyperglycemic Patients Hospitalized in Intensive Care Unit

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-7rjx3k

Enrollment

Unknown

Registered

2017-12-12

Start date

2017-01-23

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Experimental group: 40 healthy individuals of both sexes will receive two industrialized enteral formulas (25 grams of free carbohydrate) totaling 10 enteral formulas tested. Ingested volumes varied a

Dietary supplement

SP6.051.227

Eligibility

Age

18 Years to 69 Years

Inclusion criteria

Inclusion criteria: From 18 to 69 years of age; stable body weight; body mass index (BMI) between 18.5 and 24.9 kg / m2; normal glucose tolerance; without diabetes or pre-diabetes; no history of eating disorders; without gastrointestinal disturbances; no medications that affect glucose tolerance; without pregnancy; without breastfeeding; not intolerant or allergic to any of the foods

Exclusion criteria

Exclusion criteria: Volunteers using medications that could interfere with glycemia; which showed instability of body weight; any metabolic disease (diabetes mellitus; hypoglycemia; hypothyroidism)

Design outcomes

Primary

Measure	Time frame
Determination of the glycemic index of ten industrialized enteral formulas commonly used in clinical practice, based on the method recommended by the Food and Agriculture Organization. For the determination of the GI of any food, the FAO recommends that it be offered to at least 6 healthy individuals, as well as the standard food, in this case a standardized GI glucose solution. To do this, each participant will perform the two formulas test and the glucose solution test, and the GI values of the formulas will be determined by the ratio of the area below the glycemic response curve of the enteral formula and the glucose solution, value multiplied by 100, so that the GI is expressed as a percentage. The evaluation period will comprise the interval of 3 to 5 days for each experiment (offer of two formulas and later offer of the standardized glucose solution).	—

Measure

Time frame

Determination of the glycemic index of ten industrialized enteral formulas commonly used in clinical practice, based on the method recommended by the Food and Agriculture Organization. For the determination of the GI of any food, the FAO recommends that it be offered to at least 6 healthy individuals, as well as the standard food, in this case a standardized GI glucose solution. To do this, each participant will perform the two formulas test and the glucose solution test, and the GI values of the formulas will be determined by the ratio of the area below the glycemic response curve of the enteral formula and the glucose solution, value multiplied by 100, so that the GI is expressed as a percentage. The evaluation period will comprise the interval of 3 to 5 days for each experiment (offer of two formulas and later offer of the standardized glucose solution).

—

Secondary

Measure	Time frame
Secondary outcomes are not expected	—

Countries

Brazil

Contacts

Public ContactJéssica Tosatti

Universidade Federal de Minas Gerais - UFMG

jesstosatti@gmail.com+55 (31) 35864614

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 21, 2026

Determination of Glycemic Response after Ingestion of Industrialized Enteral Diets Usually Used in Clinical Practice

Conditions

Related papers

Interventions

Sponsors

Eligibility

Inclusion criteria

Exclusion criteria

Design outcomes

Primary

Secondary

Countries

Contacts

Outcome results